
Sequel is a digital family office for athletes, artists, and entrepreneurs that invests in companies advancing humanity, with a focus on climate tech, sports tech, health and wellness, and financial inclusion. The firm participates in seed through Series C rounds.
Average disclosed round size is $27.3M (across 21 rounds with reported amounts).
Portfolio
19
Fund Size
—
Top Stage
Series A
Last 12 Mo
3
Team
TC
Tim Connor
Managing Director
AT
Alberto Tenconi
Partner
JM
Jeff Monk
Sequel Growth
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
29 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series A | $50M | Jul 2026 | |
| Seed | $3.1M | Jan 2026 | |
| Series B | $25M | Nov 2025 | |
| Series A | — | Sep 2025 | |
| Series A | — | Sep 2025 | |
| Series A | — | Sep 2025 | |
| Series A | — | Jan 2025 | |
| Seed | $4M | Nov 2024 | |
| Series A | $40M | Oct 2020 | |
| Growth | — | Jan 2018 | |
| Series B | $25M | Apr 2013 | |
| Series B | $25M | Jan 2013 | |
| Series C | $10M | Sep 2011 | |
| GGlobeImmune | Series B | $38.4M | Jan 2010 |
| AAztek Networks | Unknown | $7.5M | Jan 2009 |
| Unknown | $15M | Jan 2009 | |
| Series B | $10M | Jan 2009 | |
| SSierra Neuropharmaceuticals, Inc. | Series A | — | Jul 2008 |
| SSierra Neuropharmaceuticals, Inc. | Series A | — | Jan 2008 |
| GGlobeImmune | Series C | $41.2M | Sep 2007 |
| SSkyeTek | Series C | $10M | Jul 2007 |
| Series B | $101M | Jan 2007 | |
| GGlobeImmune | Series B | $38.4M | Jan 2006 |
| RReplidyne | Unknown | $62M | Jan 2005 |
| GGlobeImmune | Series A | — | Jan 2003 |
Page 1 of 2
Top Co-Investors
Morgenthaler Ventures8 shared
firstminute capital4 shared
Portfolio Ventures3 shared
Puma Growth Partners3 shared
Playfair Capital3 shared
Guinness Ventures3 shared
Koro Capital3 shared
Adams Street Partners3 shared
Costanoa Ventures3 shared
General Catalyst3 shared
4490 Ventures2 shared
True Ventures2 shared
SEED Capital2 shared
Forerunner Ventures2 shared
Menlo Ventures2 shared
TMV2 shared
Radical Ventures2 shared
Factorial Capital2 shared
SV Angel2 shared
Felicis2 shared
Last updated: 20 October 2026